Remove Arrhythmia Remove Medicare Remove Reimbursement
article thumbnail

A Paradigm Shift in Electrophysiology Reimbursement

Vector Remote

What Clinics Can Do to Protect the Diagnosis and Treatment of Cardiac Arrhythmias Scope of Reimbursement Cuts The release of the annual Proposed Medicare Physician Fee Schedule is an event that business leaders and caregivers in healthcare anxiously anticipate.

article thumbnail

All About Cardiac Remote Patient Monitoring Software

Vector Remote

Cardiac devices managed by RPM software are reducing hospital admissions and time to diagnosis and treatment for patients with arrhythmias and heart failure. What’s Next in Cardiac Remote Patient Monitoring Software ?

article thumbnail

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

DAIC

The cohort receiving the lowest dose of 20 million cells has been initiated with no treatment-emergent adverse events, arrhythmias, rejection, or allergic response. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement. The first author of the study is R.